The latest market report published by Credence Research, Inc. “ Medical biosensors Market – Growth, Future Prospects, and Competitive Analysis, 2018-2026″ the medical biosensors market was valued at US $ 9.2 Bn in 2017 and expected to reach US $ XX Bn by 2026 at a CAGR of 7.2% during the forecast period from 2018 to 2026.
Market Insights
The global medical biosensors market shows productive growth during the forecast period from 2018 to 2026 majorly attributed to increase in the prevalence of diabetes globally. Novel technology development in wearable & non-wearable devices, the rise in manufacturing and demand for glucose monitor biosensors, high demand for home-based POC (point-of-care) devices and nanotechnology-based biosensors are enhancing the growth of the global market , The major factors driving the overall growth are increasing applications in medical diagnostics; drug development, genomics, biotechnology and home care are further in demand for medical biosensors globally.
The complete report is available at https://www.credenceresearch.com/report/medical-biosensors-market
Medical diagnostics segment dominate the global market, as the consumption of glucose. In addition, various application of medical biosensors in bimolecular, microarray, genome testing and other toxicity detections is mapping the global trend. Moreover, medical biosensors are used in the early diagnosis of diseases such as cancer and HIV. During the forecast period. For example, new technology assessment in electrochemical medical biosensors that identifies the levels of anti-oxidants has turned out to be useful in supporting the strength of the individual. The new launch of new medical biosensors wants to impel the overall growth of the market. For instance, in January 2018, scientists developed a flexible and ultra-thin biosensor for glucose monitoring, which can be used in a contact lens and a watch.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59393
In addition, increasing advancements in R & D for medical biosensors technology, implementation of point of care diagnostics, availability of medical biosensors in home care, government and organizational support for various biomarker testing, molecular diagnostic and genomic testing applications are also going to track revenue growth during the forecast period.
However, manufacturers are looking for as many as possible of the existing medical biosensors lacquer long-term constancy, miniaturization in medical biosensors carriages huge technical challenge, some medical biosensors are excessively expensive for commercial production, and short lifespan of a biomolecule are few factors limiting the growth of the medical biosensors market globally. Other external factors include governing bodies primarily in the US, Germany, India, China, and Japan, and other products in home care and other healthcare settings.
Key Market Movements:
- Globally, the medical biosensors market continues to show a profitable growth with a CAGR of 7.2% for the period from 2018 to 2026
- Higher technology assessment in the microstream equipment segment is gaining traction in the market
- Latin America, Eastern Europe, and the Asia Pacific to show promising opportunities during the forecast period due to rising awareness, adoption of new medical technology in the home care and point of care segment
- Growing number of advanced healthcare settings, easy accessibility of branded equipment, and increasing healthcare spending in developing nations along with rising cases for asthma will contribute to the growth of the market. Major players in this vertical are Pinnacle Technology, Inc., Polestar Technologies Inc., Eastprint Incorporated, DuPont Biosensor Materials, Biosensors International Group, Ltd., Surfix BV, World Precision Instruments, Inc., Ercon, Inc., ACON Laboratories, Inc., Siemens Healthcare Diagnostics Inc., Innovative Biosensors, Inc., EG & IC Sensors, Inc., Molecular Devices, LLC., Abbott Laboratories, Inc., Nova Biomedical Corporation, ACCESS BIO, INC., Silicon Kinetics, Bio-Rad Laboratories, Inc. and others.
Table of Content
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Medical Biosensors Market Portraiture
2.2. Global Medical Biosensors Market, By Technology Type, 2017 (US$ Mn)
2.3. Global Medical Biosensors Market, By Application, 2017 (US$ Mn)
2.4. Global Medical Biosensors Market, by Geography, 2017 Vs 2026 (Value %)
……………………………..
Chapter 7. Company Profiles
7.1. Biosensors International Group, Ltd.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Pinnacle Technology, Inc.
7.3. Polestar Technologies Inc.
7.4. Eastprint Incorporated
7.5. DuPont Biosensor Materials
7.6. Surfix BV
7.7. World Precision Instruments, Inc.
7.8. Ercon, Inc.
7.9. ACON Laboratories, Inc.
7.10. Siemens Healthcare Diagnostics Inc.
7.11. Innovative Biosensors, Inc.
7.12. EG & IC Sensors, Inc.
7.13. Molecular Devices, LLC.
7.14. Abbott Laboratories, Inc.
7.15. Nova Biomedical Corporation
7.16. ACCESS BIO, INC.
7.17. Silicon Kinetics
7.18. Bio-Rad Laboratories, Inc.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59393
About Us
Credence Research is a worldwide research and counseling service that serves driving organizations, governments, non-legislative associations, and not-for-benefits. Their assistance with their enduring enhancements to their execution and understanding of their most imperative objectives. Over almost a century, we’ve made a firm extraordinarily prepared for this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST # 429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph .: 1-800-361-8290
Website: http://www.credenceresearch.com